J. Mark Cline, DVM PhD

Professor of Pathology (Comparative Medicine)

Diplomate, ACVP: Veterinary Pathology; Director, Postdoctoral Fellowships in Comparative Medicine and Summer Research Fellowships; Assistant Director, Diagnostic Services: Animal Resources Program

Tel: 336-716-1564
Fax: 336-716-1515
jmcline@wakehealth.edu  

Faculty Profile

Current Research:

Work in my laboratory focuses on histopathologic and immunohistochemical methods for characterization of pre-neoplastic lesions and neoplasms. My work concerns the effect of hormonal therapies (hormone replacement after menopause, oral contraceptives, and others) on breast and uterine cancer risk. This work involves the characterization of regulatory changes and pre-cancerous lesions in the endometrium and mammary gland of macaques receiving the various hormonal therapies. Endpoints in these studies are changes in expression of proliferation markers (for example, Ki-67), estrogen and progesterone receptors, growth factor receptors, markers of cell death (apoptosis), and the development of morphologically detectable preneoplastic changes. Soy isoflavones (phytoestrogens) are also being studied, as a dietary alternative to postmenopausal hormonal replacement therapy. Work to date indicates that hormonal regulation of the breast and endometrium differ in postmenopausal animals, and that the combined estrogen-progestin therapy that prevents endometrial cancer increases proliferation in breast epithelial cells and may therefore increase the risk of breast cancer. Our most recent and exciting results indicate that dietary soy supplementation may decrease estrogen-induced cell proliferation and cancer risk in the breast and uterus.

 

JMClineFig1

FIGURE 1: Breast epithelium stained with an antibody to the proliferation marker Ki67. Brown staining indicates proliferation and an associated increase in cancer risk. 

JMClineFig2

FIGURE 2: Ki67 (proliferation marker) staining of breast and endometrium, in animals given estrogen (E2) or a high-soy diet (Soy) or the combination. These results suggest that dietary soy may decrease breast and uterine cancer risk.

Publications:

Link to PubMed Database

Quick Reference

Section Head:
J. Mark Cline, DVM, PhD, DACVP

Tel: 336-716-1564

Department of Pathology
Comparative Medicine
WF School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
Find A Doctor Ways to Give
Last Updated: 08-06-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.